Congenital Toxoplasmosis in Algeria: What Expectant Mothers Need to Know
"A review of cases reveals critical insights into prevention and management of this potentially serious condition."
During pregnancy, a mother's health directly impacts her developing child. Infections that are typically mild can pose significant risks. One such infection is toxoplasmosis, caused by the parasite Toxoplasma gondii. While many adults experience toxoplasmosis with few or no symptoms, if a woman contracts it during pregnancy, the parasite can cross the placenta and cause congenital toxoplasmosis (CT) in the fetus.
Congenital toxoplasmosis can lead to a range of health problems in newborns, from mild, unnoticeable issues to severe neurological and ocular damage. Given these potential consequences, understanding the risks, prevention strategies, and management approaches is crucial for expectant mothers and healthcare providers. Although congenital toxoplasmosis is not common, lack of awareness and preventive strategies can be detrimental.
This article explores the topic of congenital toxoplasmosis in Algeria based on a review conducted at the Centre National de Référence (CNR) Toxoplasmose, Institut Pasteur d'Algérie. By examining the data and findings of this study, we will provide expectant mothers and healthcare providers with information to better understand, prevent, and manage congenital toxoplasmosis.
Global Burden
Biology Insights reports that acute toxoplasmosis infection during pregnancy affects roughly 1.1% of pregnancies worldwide, although rates vary significantly by region. The same source estimates congenital toxoplasmosis at 1.5 per 1,000 live births globally, or about 190,100 cases each year. These figures describe a worldwide burden rather than Algeria-specific incidence.
Diagnostic Challenges
A 2023 review examined current congenital toxoplasmosis diagnostic methods and their disadvantages. Its authors searched PubMed, Cochrane, and EBSCO for publications from the preceding 10 years. The review also considered how new perspectives and technological advances might improve diagnosis.
Unveiling the Scope: Understanding Congenital Toxoplasmosis in Algeria
A study was conducted at the Centre National de Référence (CNR) Toxoplasmose, Institut Pasteur d'Algérie, between 2002 and 2017. Researchers reviewed 49 cases of congenital toxoplasmosis that were diagnosed during that period. The aim was to better understand the clinical and biological characteristics of the infection in Algeria.
- Most infections occurred during the first trimester (29 cases).
- A smaller number of infections occurred in the second (4 cases) and third trimesters (5 cases).
- In 11 cases, the exact timing of the infection could not be determined.
- Spiramycin, an antibiotic, was prescribed to 31 pregnant women.
- Fetal ultrasounds were not helpful in diagnosing congenital toxoplasmosis in these cases.
- Out of 47 live births, 40 newborns were asymptomatic, while 7 showed obvious signs of the infection.
- Neurological issues (with or without skin rash) were the most common symptoms among the symptomatic newborns.
- Western blot testing was the most sensitive method for diagnosing congenital toxoplasmosis in newborns.
- Most newborns (65.95%) were treated with pyrimethamine-sulfadoxine.
- There were two early deaths, four cases of chorioretinitis (inflammation of the retina and choroid), and three cases of neurological damage.
Tunisia’s Diagnostic Evidence
Recent Tunisian research supports combining infant serology, molecular testing, and comparative mother–infant Western blotting in neonatal diagnosis. The review identifies de novo IgM or IgA detection and comparative Western blotting as useful approaches, particularly for asymptomatic infections that neonatal PCR may miss. A separate Tunisian study reports variability in the date when Western blot tests become positive.
Timing and Detection Gaps
The clinical picture of congenital toxoplasmosis varies with the gestational age when maternal infection occurs and is transmitted, as well as with whether pregnant women are systematically screened and how frequently screening is performed. A SYROCOT meta-analysis found that transmission was reduced by half when treatment began three weeks rather than eight weeks after the estimated maternal infection. These findings show why delayed treatment and inconsistent detection can undermine outcomes.
Variation in Management
Congenital toxoplasmosis results from transplacental passage of Toxoplasma gondii tachyzoites, and the risk of transmission depends on gestational age and clinical management. A 2023 review notes that the parasite’s epidemiology varies from country to country. This variation contributes to a lack of international consensus on screening, diagnosis, and management.
Protecting Future Generations: Steps to Improve Outcomes
The review of congenital toxoplasmosis cases in Algeria underscores the need for a multi-pronged approach to prevention and management. By raising awareness, improving prenatal care, and ensuring access to prompt treatment, healthcare providers and expectant mothers can work together to reduce the burden of this infection and improve outcomes for future generations.
Value of Early Screening
A systematic review and individual-patient-data meta-analysis evaluated how the timing and type of prenatal treatment affected mother-to-child transmission and clinical manifestations before one year of age. Expert commentary reports that diagnostic strategies remain highly heterogeneous worldwide, ranging from intensive prenatal screening to no systematic testing. Where screening programs are implemented, they promote earlier diagnosis and treatment, with a positive impact on transmission and disease severity.
Gestational Timing Matters
The State of the Art review reports that infection during the first or second trimester may lead to miscarriage, estimated at around 3% of all cases, or stillbirth. Infants infected earlier in pregnancy frequently show severe neurological or ocular disease. When infection occurs later in pregnancy, neonatal disease may be less severe or asymptomatic.